GoodRx Holdings Inc
For the period ended Mar 31, 2024. Filed May 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 9, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Insider Trading Arrangements
During the three months ended March 31, 2024, none of our directors or officers (as defined in Section 16 of the
Exchange Act), adopted orterminated any contract, instruction or written plan for the purchase or sale of our securities that
was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any "non-Rule 10b5-1
trading arrangement" (as defined in Item 408(c) of Regulation S-K of the Exchange Act).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.